BrightGene Bio-medical Technology(SH:688166) Shang Hai Zheng Quan Bao·2025-11-21 19:08Core Viewpoint - The company, Bright Gene, is set to hold a Q3 2025 earnings presentation on December 2, 2025, to discuss its financial performance and address investor inquiries [2][3]. Group 1: Meeting Details - The earnings presentation will take place on December 2, 2025, from 13:00 to 14:00 [4]. - The meeting will be conducted via the Shanghai Stock Exchange's online roadshow center [4][6]. - Participants will include the Chairman and General Manager, Mr. Yuan Jiandong, the Chief Financial Officer, Mr. Zou Yuanlai, and other key executives [4]. Group 2: Investor Participation - Investors can participate in the meeting by logging into the Shanghai Stock Exchange's roadshow center on the scheduled date [5]. - A pre-question submission period is available from November 25 to December 1, 2025, allowing investors to submit questions via the website or email [5]. Group 3: Contact Information - The company’s securities department can be contacted for further inquiries [6][7]. - The official email for investor relations is IR@bright-gene.com [7].